Back to News
Retail news

CVS Pays Record Fine for PSE Sales

The drugstore chain has agreed to pay a $75 million fine and forfeit $2.6 million in profits for unlawfully selling pseudoephedrine, a key ingredient in the manufacture of methamphetamine, in California and Nevada in 2007 and 2008.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0